AUG 13, 2026 · PHASE 3 TRIAL
A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects
ClinicalTrials.gov
This is a registry record of a Phase 3 RCT currently recruiting, with no posted results; the study design is sound but evidence cannot be assessed until outcomes are reported.
Reported
PhasePHASE 3
Planned enrollment675
Treatment duration52 weeks